Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MBIN | NMRK |
|---|---|---|
| Price | $49.72 | $12.58 |
| Change today | ▼ 0.46% | ▼ 0.55% |
| Market cap | $2.28B | $2.28B |
| Return, 3 months | +5.0% | -19.3% |
| Return, year to date | +47.0% | -26.7% |
| Return, 1 year | +55.8% | -28.0% |
| P/E (TTM) | 10.0 | 15.7 |
| P/B | 1.2 | 1.6 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 0.84% | 1.19% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +28.7% | +59.0% |
| Analyst buy share | 50% | 100% |
| RSI (14) | 37 | 31 |
| 30-day volatility | 18.2% | 33.8% |
| Max drawdown, 1 year | -13.3% | -36.3% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
